US2004259134A1PendingUtilityA1

Glycerol as a predictor of glucose tolerance

Assignee: WHITEHEAD BIOMEDICAL INSTPriority: Oct 22, 1999Filed: Apr 19, 2004Published: Dec 23, 2004
Est. expiryOct 22, 2019(expired)· nominal 20-yr term from priority
C12Q 1/48C12N 9/1205C12Q 1/485G01N 33/66G01N 2333/91215G01N 2800/042G01N 2500/00G01N 2800/52C12Y 207/0103C12Q 2600/156C12Q 1/6883G01N 33/6893
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . An isolated nucleic acid molecule comprising a portion of SEQ ID NO: 3, wherein said portion is at least 10 nucleotides in length and includes nucleotide position 29 of exon 10 of a glycerol kinase (GK) gene, and wherein said nucleic acid molecule comprises a mutant allele of said GK gene at said nucleotide position 29.  
     
     
         2 . A complement strand of a nucleic acid molecule, wherein said nucleic acid molecule comprises a portion of SEQ ID NO: 3, wherein said portion is at least 10 nucleotides in length and includes nucleotide position 29 of exon 10 of a glycerol kinase (GK) gene, and wherein said nucleic acid molecule comprises a mutant allele of said GK gene at said nucleotide position 29.  
     
     
         3 . The nucleic acid molecule of  claim 1 , wherein said portion is at least 20 nucleotides in length.  
     
     
         4 . The nucleic acid molecule of  claim 1 , wherein said portion is at least 50 nucleotides in length.  
     
     
         5 . The nucleic acid molecule of  claim 1 , wherein said mutant allele comprises a nucleotide selected from the group consisting of a guanosine, a thymidine, and a cytidine at said nucleotide position 29.  
     
     
         6 . The nucleic acid molecule of  claim 5 , wherein said nucleic acid molecule comprises a guanosine at said nucleotide position 29.  
     
     
         7 . The nucleic acid molecule of  claim 1 , wherein the nucleic acid molecule is selected from the group consisting of DNA, RNA, and polypeptide nucleic acid (PNA).  
     
     
         8 . The nucleic acid molecule of  claim 1 , wherein the nucleic acid molecule comprises a label.  
     
     
         9 . The nucleic acid molecule of  claim 8 , wherein the label is selected from the group consisting of a radioisotope, a fluorescent compound, an enzyme, and an enzyme cofactor.  
     
     
         10 . The nucleic acid molecule of  claim 1 , wherein the nucleic acid molecule is immobilized on a solid support.  
     
     
         11 . The nucleic acid molecule of  claim 10 , wherein the nucleic acid molecule is one of an array of two or more different nucleic acid molecules immobilized on said solid support.  
     
     
         12 . An isolated nucleic acid molecule comprising SEQ ID NO: 3, wherein said nucleic acid molecule comprises a mutant allele at nucleotide position 29 of exon 10 of a glycerol kinase (GK) gene.  
     
     
         13 . A complement strand of a nucleic acid molecule, wherein said nucleic acid molecule comprises SEQ ID NO: 3, wherein said nucleic acid molecule comprises a mutant allele at nucleotide position 29 of exon 10 of a glycerol kinase (GK) gene.  
     
     
         14 . The nucleic acid molecule of  claim 12 , wherein said nucleic acid molecule is at least 250 nucleotides in length.  
     
     
         15 . The nucleic acid molecule of  claim 12 , wherein said mutant allele comprises a nucleotide selected from the group consisting of a guanosine, a thymidine, and a cytidine at said nucleotide position 29.  
     
     
         16 . The nucleic acid molecule of  claim 15 , wherein said nucleic acid molecule comprises a guanosine at said nucleotide position 29.  
     
     
         17 . The nucleic acid molecule of  claim 12 , wherein the nucleic acid molecule is selected from the group consisting of DNA, RNA, and polypeptide nucleic acid (PNA).  
     
     
         18 . The nucleic acid molecule of  claim 12 , wherein the nucleic acid molecule comprises a label.  
     
     
         19 . The nucleic acid molecule of  claim 18 , wherein the label is selected from the group consisting of a radioisotope, a fluorescent compound, an enzyme, and an enzyme cofactor.  
     
     
         20 . The nucleic acid molecule of  claim 12 , wherein the nucleic acid molecule is immobilized on a solid support.  
     
     
         21 . The nucleic acid molecule of  claim 20 , wherein the nucleic acid molecule is one of an array of two or more different nucleic acid molecules immobilized on said solid support.  
     
     
         22 . An isolated nucleic acid molecule which specifically hybridizes to a portion of SEQ ID NO: 3, wherein said portion is at least 10 nucleotides in length and includes nucleotide position 29 of exon 10 of a glycerol kinase (GK) gene, and wherein said nucleic acid molecule comprises a mutant allele of said GK gene at said nucleotide position 29.  
     
     
         23 . An isolated nucleic acid molecule consisting of a portion of SEQ ID NO: 3, wherein said portion is at least 10 nucleotides in length and includes nucleotide position 29 of exon 10 of a glycerol kinase (GK) gene, and wherein said nucleic acid molecule comprises a mutant allele of said GK gene at said nucleotide position 29.  
     
     
         24 . An isolated nucleic acid molecule consisting of SEQ ID NO: 3, wherein said nucleic acid molecule comprises a mutant allele at nucleotide position 29 of exon 10 of a glycerol kinase (GK) gene at said nucleotide position 29.

Join the waitlist — get patent alerts

Track US2004259134A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.